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Introduction: Over 70% of traumatic brain injuries (TBI) are classified as mild (mTBI),
which present heterogeneously. Associations between pre-injury comorbidities and
outcomes are not well-understood, and understanding their status as risk factors may
improve mTBI management and prognostication.
Methods: mTBI subjects (GCS 13–15) from TRACK-TBI Pilot completing 3- and
6-month functional [Glasgow Outcome Scale-Extended (GOSE)] and post-concussive
outcomes [Acute Concussion Evaluation (ACE) physical/cognitive/sleep/emotional
subdomains] were extracted. Pre-injury comorbidities >10% incidence were included
in regressions for functional disability (GOSE ≤ 6) and post-concussive symptoms by
subdomain. Odds ratios (OR) and mean differences (B) were reported. Significance was
assessed at p < 0.0083 (Bonferroni correction).
Results: In 260 subjects sustaining blunt mTBI, mean age was 44.0-years and 70.4%
were male. Baseline comorbidities >10% incidence included psychiatric-30.0%, cardiac
(hypertension)-23.8%, cardiac (structural/valvular/ischemic)-20.4%, gastrointestinal-
15.8%, pulmonary-15.0%, and headache/migraine-11.5%. At 3- and 6-months
separately, 30.8% had GOSE ≤ 6. At 3-months, psychiatric (GOSE ≤ 6: OR = 2.75,
95% CI [1.44–5.27]; ACE-physical: B = 1.06 [0.38–1.73]; ACE-cognitive: B = 0.72
[0.26–1.17]; ACE-sleep: B = 0.46 [0.17–0.75]; ACE-emotional: B = 0.64 [0.25–1.03]),
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headache/migraine (GOSE ≤ 6: OR = 4.10 [1.67–10.07]; ACE-sleep: B = 0.57
[0.15–1.00]; ACE-emotional: B = 0.92 [0.35–1.49]), and gastrointestinal history
(ACE-physical: B = 1.25 [0.41–2.10]) were multivariable predictors of worse outcomes.
At 6-months, psychiatric (GOSE ≤ 6: OR = 2.57 [1.38–4.77]; ACE-physical: B = 1.38
[0.68–2.09]; ACE-cognitive: B = 0.74 [0.28–1.20]; ACE-sleep: B = 0.51 [0.20–0.83];
ACE-emotional: B = 0.93 [0.53–1.33]), and headache/migraine history (ACE-physical:
B = 1.81 [0.79–2.84]) predicted worse outcomes.
Conclusions: Pre-injury psychiatric and pre-injury headache/migraine symptoms are
risk factors for worse functional and post-concussive outcomes at 3- and 6-months
post-mTBI. mTBI patients presenting to acute care should be evaluated for
psychiatric and headache/migraine history, with lower thresholds for providing TBI
education/resources, surveillance, and follow-up/referrals.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT01565551.
Keywords: functional impairment, mild traumatic brain injury, post-concussive symptoms, pre-injury
comorbidities, prognosis
INTRODUCTION
Traumatic brain injury (TBI) remains a significant cause of
morbidity and mortality worldwide. In 2013 ∼2.8 million TBI
cases were recorded annually in the United States (U.S.) (1),
which is a 160% increase from 2007 (2). Updated estimates
suggest closer to 4 million, due to subpopulations of patients who
do not seek care due to either inadequate access or perceived
lack of need (2–4). Over 70% of TBI is classified as “mild
(mTBI)” defined by Glasgow Coma Scale (GCS) score 13-15 (3,
5), which present heterogeneously with a range of demographic
and clinical risk factors. Although a substantial portion of mTBI
patients fully recover without intervention, up to 50% suffer long-
term functional and/or neuropsychological sequelae, leading to a
substantial burden on both patients and the healthcare system (3,
6). This heterogeneity poses a problem in the clinic, as some risk
factors are conserved while others differ across different outcome
instruments. Whether predictors differ across different outcome
time points is also unclear, and hence it remains challenging
to risk-stratify patients who will benefit most from additional
resources and follow-up in both acute and chronic settings after
mTBI (7).
In the orthopedic and geriatric literature, it is recognized
that pre-existing conditions impact outcomes after acute illness
or injury. However,there is a paucity of research investigating
the relationship between pre-injury comorbidities and outcome
after mTBI. A number of studies have focused exclusively on
psychiatric comorbidities, and PTSD, on mTBI outcome (8–12).
Some studies consider the number of rather than types of
comorbidities (13), while others focus on mTBI as a risk factor
for worsened systemic conditions but not the reverse (14–18).
Pre-injury comorbidities are routinely collected during standard
clinical interview and documented in the medical record, which
underscores their utility as a readily available data source in both
acute and ambulatory care settings without increasing time or
cost burden. Elucidation of the associations between certain pre-
injury conditions and domains of outcome will help clinicians
and researchers better understand contributors and modifiers of
injury in this heterogeneous group of patients, and may improve
early risk stratification of and resource allocation for those at risk
for unfavorable recovery.
Systemic medical conditions intrinsically influence physical
and cognitive reserve at baseline, and may exert differential
effects on recovery in the brain-injured patient. To date, many
mTBI studies have understandably excluded patients with pre-
injury comorbidities to reduce outcome variability when isolating
risk factors (19). Unfortunately, this hinders the clinician’s
approach to complex patients with pre-injury conditions who
suffer mTBI. In the current analysis, we characterize the baseline
systemic comorbidities of a prospectively collected multicenter
mTBI sample with a high prevalence of pre-injury comorbidities,
and investigate the relationships between systemic comorbidities
and 3- and 6-month functional and post-concussive outcomes.
METHODS
The prospective Transforming Research and Clinical Knowledge
in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study was
conducted at three U.S. Level I trauma centers [Zuckerberg
San Francisco General Hospital (California), University of
Pittsburgh Medical Center (Pennsylvania), University Medical
Center Brackenridge (Austin, Texas)] using the National
Institute of Neurological Disorders and Stroke (NINDS) TBI
Common Data Elements (CDEs) (20–24). Inclusion criteria
for TRACK-TBI Pilot were age ≥16-years, external force
head trauma, presentation to enrolling center, and clinically-
indicated head computed tomography (CT) scan<24 h of injury.
Exclusion criteria were pregnancy, ongoing life-threatening
disease (e.g., end-stage malignancy), police custody, involuntary
Frontiers in Neurology | www.frontiersin.org 2 April 2019 | Volume 10 | Article 343
Yue et al. Pre-injury Comorbidities and mTBI Outcome
psychiatric hold, and non-English speakers due to multiple
outcome measures administered and/or normed only in
English. As the goal of this analysis was to evaluate the
associations between baseline comorbidities and outcomes,
subjects with emergency department (ED) admission GCS
13–15 who completed the Glasgow Outcome Scale-Extended
(GOSE) and Acute Concussion Evaluation (ACE) at 3-
and 6-months were included. To minimize confounding
of TBI outcomes, subjects with history of central nervous
system malignancy, cerebrovascular anomaly/accident, human
immunodeficiency virus/acquired immunodeficiency syndrome,
and/or developmental delay were excluded.
Eligible subjects were enrolled by convenience sampling
from years 2010–2012. Institutional Review Board approval
was obtained at each participating site. Informed consent was
obtained prior to enrollment. For subjects unable to provide
consent due to injury, surrogate consent was obtained. Subjects
were re-consented, if cognitively able, during the course of
clinical care and/or follow-up timepoints for study participation.
Demographic and Clinical Variables
Subjects underwent a baseline assessment at ED admission.
Variables were collected according to NINDS CDE version 1
(21, 23, 24). Twelve CDE pre-injury comorbidity categories
(i.e., comorbidities present at baseline prior to the index
mTBI of enrollment) were collected by standard checklists
through self-report and chart abstraction, including cardiac-
hypertension, cardiac-structural/ischemic/valvular, diabetes
mellitus, gastrointestinal, hematologic, headache/migraine,
hepatic, pulmonary, psychiatric, renal, seizure, and thyroid.
Outcome Measures
Outcome measures were collected through in-person or phone
interview at 3- and 6-months. To focus on functional
disability and post-concussive symptoms, the following measures
were analyzed:
Glasgow Outcome Scale-Extended (GOSE): Structured
interview which provides an overall measure of disability
based on cognition, independence, employability, and
social/community participation, and has been widely used
as a standard outcome measure for TBI studies (25). Scores
include: 1 = dead, 2 = vegetative state, 3 = lower severe
disability, 4 = upper severe disability, 5 = lower moderate
disability, 6 = upper moderate disability, 7 = lower good
recovery, and 8 = upper good recovery. A score of 8 reflects
recovery to baseline without new disability. For the current
analysis, the ordinal GOSE was dichotomized into “good
recovery (GOSE 7–8)” vs. “moderate disability or worse (GOSE
≤ 6),” consistent with prior reports (26, 27).
Acute Concussion Evaluation (ACE): First reported by a
consensus sports neuropsychology panel in 1998 and adopted by
the U.S. Centers for Disease Control and Prevention (CDC) in
2006 (28, 29). It contains 22 specific post-concussive symptoms
classified into 4 domains: physical (10 symptoms), cognitive (4
symptoms), sleep (4 symptoms), and emotional (4 symptoms).
Subjects were queried regarding the presence/absence of each
symptom and the number of symptoms per domain were totaled
for analysis.
Statistical Analysis
Descriptive statistics were assessed using means and standard
deviations (SD) for continuous variables and proportions for
categorical variables. Three- and six-month functional outcomes
were analyzed using logistic regression (GOSE ≤ 6 vs. 7–8),
and post-concussive outcomes were analyzed by domain using
linear regression (number of symptoms). As variables of interest,
pre-injury comorbidities with >10% incidence were included
in multivariable models for outcome, controlling for age, sex,
education (years), ED admission GCS, and presence/absence of
intracranial abnormalities on CT. Multivariable odds ratios (OR)
and associated 95% confidence intervals (CI) were reported for
each predictor. Significance was assessed at p < 0.0083 using the
Bonferroni correction (0.05 ÷ 6 comorbidities). Analyses were
performed using Statistical Package for the Social Sciences (SPSS)
version 24 (IBM Corp., Chicago, IL).
RESULTS
Overall, 260 mTBI subjects had a mean age of 44.0 ± 18.7-
years, 70.4% were male, 78.6% were Caucasian, and 42.3% were
head CT+. Baseline comorbidities >10% incidence included
psychiatric (30.0%), cardiac-hypertension (23.8%), cardiac-
structural/valvular/ischemic (20.4%), gastrointestinal (15.8%),
pulmonary (15.0%), and headache/migraine (11.5%) (Table 1).
At 3- and 6-months, 30.8% had GOSE ≤ 6. Additional
demographic and clinical variables are shown in Table 1.
On multivariable analysis at 3-months, psychiatric history
was a predictor for functional disability (GOSE≤6: OR = 2.75,
95% CI [1.44–5.27]) and all domains of post-concussive
symptoms (ACE-physical: B = 1.06 [0.38–1.73]; ACE-cognitive:
B = 0.72 [0.26–1.17]; ACE-sleep: B = 0.46 [0.17–0.75];
ACE-emotional: B = 0.64 [0.25–1.03]). Headaches/migraine
history was a predictor for functional disability (GOSE ≤
6: OR = 4.10 [1.67–10.07]), and sleep and emotional post-
concussive symptoms (ACE-sleep: B = 0.57 [0.15–1.00]; ACE-
emotional: B = 0.92 [0.35–1.49]). Gastrointestinal history was a
predictor for physical post-concussive symptoms (ACE-physical:
B= 1.25 [0.41–2.10]) (Table 2A).
Onmultivariable analysis at 6-months, psychiatric history was
a predictor for functional disability (GOSE≤ 6: OR= 2.57 [1.38–
4.77]) and all domains of post-concussive symptoms (ACE-
physical: B = 1.38 [0.68–2.09]; ACE-cognition: B = 0.74 [0.28–
1.20]; ACE-sleep: B= 0.51 [0.20–0.83]; ACE-emotional: B= 0.93
[0.53–1.33]). Headache/migraine history was a predictor for
physical post-concussive symptoms (ACE-physical: B = 1.81
[0.79–2.84]) (Table 2B).
DISCUSSION
The heterogeneity of mTBI in risk factors and outcomes leads
to clinical challenges in patient-specific triage, treatment and
prognosis. In a comprehensive report of pre-injury comorbidities
and mTBI, we found psychiatric, cardiac, gastrointestinal,
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TABLE 1 | Demographic and clinical characteristics in 260 mTBI subjects.
Variable N (%) or mean ± SD
AGE
Years (mean, SD) 44.0 ± 18.7
SEX
Male 183 (70.4%)
Female 77 (29.6%)
EDUCATION
Years (mean, SD) 14.2 ± 2.9
MECHANISM OF INJURY
Motor vehicle accident 61 (23.5%)
Pedestrian vs. auto 37 (14.2%)
Fall 117 (45.0%)
Assault 35 (13.5%)
Struck by object 10 (3.9%)
ED ADMISSION GCS
13 9 (3.5%)
14 53 (20.4%)
15 198 (70.2%)
INTRACRANIAL CT FINDINGS
No 150 (57.7%)
Yes 110 (42.3%)
ED DISPOSITION
Discharge home 88 (38.8%)
Hospital ward admit 109 (41.9%)
ICU admit 63 (24.2%)
PRE-INJURY COMORBIDITIES
Psychiatric history 78 (30.0%)
Cardiac-hypertension history 62 (23.8%)
Cardiac-structural/ischemic/valvular history 53 (20.4%)
Gastrointestinal history 41 (15.8%)
Pulmonary history 39 (15.0%)
Headache/migraine history 30 (11.5%)
Seizure history 22 (8.5%)
Diabetes history 21 (8.1%)
Hepatic history 20 (7.7%)
Renal history 15 (5.8%)
Thyroid history 13 (5.0%)
Hematologic history 12 (4.6%)
3-MONTHS OUTCOMES
GOSE ≤ 6 80 (30.8%)
ACE physical 2.33 ± 2.56
ACE cognitive 0.94 ± 1.10
ACE sleep 1.38 ± 1.65
ACE emotional 1.05 ± 1.45
6-MONTHS OUTCOMES
GOSE ≤ 6 80 (30.8%)
ACE physical 2.84 ± 2.74
ACE cognitive 1.22 ± 1.18
ACE sleep 1.70 ± 1.69
ACE emotional 1.42 ± 1.52
ACE, Acute Concussion Evaluation; CT, computed tomography; ED, emergency
department; GCS, Glasgow Coma Scale; GOSE, Glasgow Outcome Scale Extended;
ICU, intensive care unit; SD, standard deviation.
pulmonary, and headache/migraine comorbidities to be of the
highest incidence. In 260 mTBI subjects, psychiatric history
was a predictor of functional disability and increased post-
concussive at 3- and 6-months controlling for demographic
and clinical variables and other pre-injury comorbidities.
Additionally, headache/migraine history was a predictor of
functional disability, sleep and emotional symptoms at 3-
months, and physical symptoms at 6-months. These results
constitute a first step to improved understanding of pre-
injury risk factors and improved awareness of subsets of
patients who may benefit from careful history taking, increased
education, and surveillance, including triage to follow-up at early
time points.
Psychiatric history is a known predictor of worsened
functional and post-concussive outcome after mTBI (30). Over
the past decade, studies have shown that baseline psychiatric
morbidity is predictive of 2-week and 6-month outcomes
separately. The multicenter UPFRONT study in the Netherlands
showed that baseline mental health disorders conferred OR
0.31–0.39 for complete functional recovery (GOSE = 8) at
6-months (31). Our study shows that not only is functional
recovery more likely to be incomplete in those with psychiatric
history, but the effect of OR 2.5–2.8 for moderate functional
disability or worse, e.g., unable to return to work, significant
social or emotional disruption, is conserved at 3- and 6-months,
in addition to the 0.5 to 1.4 more symptoms across post-
concussive symptoms domains. Recent studies illustrate that
recovery from mTBI is a non-linear process with subgroups of
patients failing to rebound from their injury, such that prognostic
models using pre-injury risk factors can be constructed to
guide post-injury management (32–34). As mTBI patients are
increasingly shown to have impairments in cognitive and
neuropsychiatric recovery, it becomes ever more important to
document and have an accurate understanding of the patient’s
baseline cognitive, psychiatric, and mental health in order to
both monitor post-injury return to baseline, and address deficits
from baseline during the process of recovery. Pertinent first
steps include documentation of priority pre-injury comorbidities
including presence and frequency of prior psychiatric and
headache symptoms, setting expectations by informing patients
with these comorbidities that their symptoms often worsen
after mTBI, providing discharge instructions for patients and
physicians to monitor whether post-injury symptomatology are
new or worse during acute follow-up, and having a lower
threshold to refer patients to follow-up with primary or
specialist care.
Headache is the most common post-concussive symptom
manifestation with 30–90% incidence (35–38). While
post-traumatic headache (PTH) is well-documented
after mTBI (39, 40), the relationship between pre-injury
headaches/migraines with long-term post-injury functional
outcomes remains understudied. Improved understanding of
this association will help to determine whether a patient’s PTH
should be considered a new entity vs. a possible exacerbation
of baseline headaches after mTBI. We showed that at baseline,
11.5% of patients suffered from headache/migraine, which
predicted post-injury functional disability and sleep and
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emotional post-concussive symptoms at 3-months, as well as
physical post-concussive symptoms at 6-months. Our results
not only support previous findings regarding the importance
of evaluating for premorbid headache/migraine as a risk factor
for PTH (40), but also show that headache/migraine history
is associated with multiple outcome domains after mTBI. In
addition to psychological factors and mental health as predictors
of 6-months outcome after mTBI (31), we demonstrate the
need to identify risk factors from other categories of pre-injury
medical history. In our study, pre-injury headache/migraine
was associated with different outcome domains between 3-
and 6-months, suggesting that deficits may continue to evolve
over time after mTBI. These findings alert both clinicians
and researchers to the need for standardized assessment
of functional disability and post-concussive symptoms at
multiple (and earlier) time points, as early interventions
post-injury may decrease maladaptive coping methods,
loss of livelihood/productivity, and healthcare costs. Along
with psychiatric history and pre-injury headache/migraine
being predictors of functional disability and post-concussive
symptoms at 3-months, we found that gastrointestinal history
also associated with physical post-concussive symptoms.
Aside from cognitive and neuropsychiatric impairments,
there is emerging interest in understanding systemic effects
of autonomic dysfunction after mTBI (41). For the first
3-months post-injury, mTBI can possibly exacerbate the
complex and non-specific nature of gastrointestinal symptoms
as reflected through physical post-concussive symptoms in
the patient.
Limitations
We studied associations between pre-injury comorbidities and
outcomes, and in consideration for not overfitting our regression
models, we limited to controlling for known predictors of mTBI
outcomes rather than all possible predictors available in our
dataset. We did not study trajectories of outcomes, nor whether
mTBI had effects on the severity of pre-injury comorbidities.
Patient recruitment is limited to Level I trauma centers capturing
a more urbanized population, and thus our findings cannot
be extrapolated to all mTBI patients. Proportions of telephone
vs. in-person follow-ups, which have been shown to influence
extent of disclosure in cancer and genetics studies (42), were
unavailable from our dataset and constitutes another limitation.
This is a study of association, hence we are unable to make
claims regarding causality or pathophysiology. We limited our
multivariable analysis to comorbidities with over 10% incidence
in the sample to provide reliable odds ratios, and future studies
of larger sample size will enable analyses of the relationship
between specific comorbidities within each organ system and
outcome. Lastly, we were limited by the variables available and
were unable to investigate whether subjects successfully triaged
to and/or completed rehabilitation programs. Our goal is to
establish a first step in assessing the importance of baseline
comorbidities on mTBI outcome, hence our findings remain
exploratory and in need of validation by future trials. Integrating
the evaluation of pre-injury comorbidities with that of other
baseline predictors not routinely collected on admission, such
as education level, may be important in the prognostication of
outcome after mTBI.
Conclusions
Amongst pre-injury comorbidities, history of psychiatric
disorder is a risk factor for decreased functional outcome
and increased post-concussive symptoms across multiple
domains, at 3- and 6-months post-injury after mTBI. History
of headache/migraine may also be a risk factor for decreased
functional outcome and increased post-concussive symptoms.
mTBI patients presenting to acute and post-discharge care
should be evaluated for history of baseline psychiatric and
headache/migraine disorders, with lower thresholds for
provision of TBI education and resources, surveillance, and
follow-up/referrals to primary and specialist care.
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